Browse by author
Lookup NU author(s): Professor Andrew FisherORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2020, The Author(s).The original version of this article omitted from the author list the 19th author Andrew Fisher, who is from the Newcastle Fibrosis Research Group, Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK. Consequently, the following was added to the Acknowledgements: ‘A.J.F. acknowledges funding support via a collaborative framework agreement between GSK and Newcastle University and from the NIHR Newcastle Biomedical Research Centre (Newcastle BRC).’ Additionally, the following was added to the Author Contributions: ‘A.J.F. obtained ethical approvals, consented patients and provided patient tissue and reviewed and approved the final manuscript.’ Finally, the following was added to the Competing Interests: ‘A.J.F. has no declarations directly related to this manuscript. His institution has received industry-academic research funding from GlaxoSmithKline R&D, Genentech, Pfizer and Nuformix. His institution has received consultancy fees from Mallinckrodt Pharmaceuticals.’ This has been corrected in both the PDF and HTML versions of the article.
Author(s): Woodcock HV, Eley JD, Guillotin D, Plate M, Nanthakumar CB, Martufi M, Peace S, Joberty G, Poeckel D, Good RB, Taylor AR, Zinn N, Redding M, Forty EJ, Hynds RE, Swanton C, Karsdal M, Maher TM, Fisher A, Bergamini G, Marshall RP, Blanchard AD, Mercer PF, Chambers RC
Publication type: Note
Publication status: Published
Journal: Nature Communications
Year: 2020
Volume: 11
Issue: 1
Print publication date: 01/12/2020
Online publication date: 11/11/2020
Acceptance date: 02/04/2016
ISSN (electronic): 2041-1723
Publisher: Nature Research
URL: https://doi.org/10.1038/s41467-020-18621-3
DOI: 10.1038/s41467-020-18621-3
PubMed id: 32917879
